Evolent Health (EVH) Interest Expenses (2016 - 2026)

Evolent Health has reported Interest Expenses for 11 years, with the latest figure at $16.9 million in Q1 2026.

• For the quarter ending Q1 2026, Interest Expenses rose 62.43% year-over-year to $16.9 million; the trailing twelve-month figure through Mar 2026 stood at $64.0 million (up 119.7% YoY), and the FY2025 full-year result was $57.5 million, up 132.47% from the prior year.
• Interest Expenses for Q1 2026 stood at $16.9 million, down from $19.0 million in the prior quarter.
• The five-year high for Interest Expenses was $19.0 million in Q4 2025, with the low at $2.1 million in Q2 2022.
• Average Interest Expenses over 5 years is $9.9 million, with a median of $10.4 million recorded in 2025.
• Year-over-year, Interest Expenses tumbled 65.76% in 2022 and surged 573.09% in 2023.
• Tracing EVH's Interest Expenses over 5 years: stood at $6.4 million in 2022, then jumped by 90.36% to $12.2 million in 2023, then tumbled by 45.09% to $6.7 million in 2024, then jumped by 182.89% to $19.0 million in 2025, then declined by 11.27% to $16.9 million in 2026.
• The last three Interest Expenses figures came in at $16.9 million (Q1 2026), $19.0 million (Q4 2025), and $16.5 million (Q3 2025), per Business Quant data.

Peer Comparison